𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA

✍ Scribed by Dr. Martina Kirstein; Corrado Baglioni


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
763 KB
Volume
134
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


The objective of this study was to establish whether human recombinant tumor necrosis factor (TNF) can significantly stimulate the proliferation of some tumor cells. Treatment with TNF had little or no effect on the growth of human tumor cells and murine NIH13T3 cells cultured in medium with high serum concentration. Two tumor lines, SK-MEL-109 melanoma and HOS osteosarcoma cells, were adapted to grow in medium supplemented with 0.5% serum. The growth of these SK-MEL-109 cells was inhibited by TNF, but that of the HOS cells was greatly stimulated by TNF in a dose-dependent way. Treatment with 10 ng/ml of TNF resulted in a two-fold increase in the rate of cell division. This effect of TNF was also shown by measuring DNA and protein synthesis. The continuous presence of TNF was not required for its mitogenic activity on HOS cells cultured with 0.5% serum, since treatment for only one day with T N F resulted in prolonged growth stimulation. The failure of TNF to promote division of cells cultured in medium with 10% serum may possibly be explained by the presence of saturating amounts of growth factors in serum. Interferons abolished the mitogenic activity of TNF on HOS cells. Furthermore, TNF did not show synergism with insulin or epidermal growth factor in stimulating growth of these cells. The level of cmyc mRNA was increased five-fold after 30 minutes of treatment with TNF. This shows that TNF is a growth factor for HOS cells and that it induces accumulation of c-myc mRNA.

Tumor necrosis factor (TNF) was detected by Carswell tors on the cell surface with high affinity, is internalized et al. (1975) in the serum of animals injected sequen-by receptor-mediated endocytosis, and degraded (Aggartially with Bacillus Calmette-Guerin or C. paruum and wal et al., 1985a;Tsujimoto et al., 1985; Baglioni et al., endotoxin. This treatment induces proliferation of mac-1985). Tumor cell lines have 1,000 to 10,000 receptors rophages, which are stimulated to secrete TNF by endo-per cell with a KD of about 2 x 10-l' M (Aggarwal et


πŸ“œ SIMILAR VOLUMES


Differential effect of tumor necrosis fa
✍ Luisa Lina Villa; Katia Brito Lins Vieira; Xu-Fang Pei; Richard Schlegel πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 582 KB

## Abstract Keratinocytes immortalized by human papillomaviruses (HPV) 16 and 18 are partially resistant to the inhibition of proliferation exerted by transforming growth factor‐β (TGF‐β). To determine if this finding reflects a generalized resistance to inhibitory cytokines, we studied the effect

Kupffer cell depletion abolishes inducti
✍ R M Rai; S Loffreda; C L Karp; S Yang; H Lin; A M Diehl πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 599 KB

that synchronize the regenerative response to liver injury Tumor necrosis factor a (TNF), initiates a cytokine and implies that hepatocytes and liver nonparenchymal cells cascade that promotes hepatocyte proliferation after are both the sources of, and the targets for, various growth-70% partial hep

Pulse treatment of human vascular endoth
✍ Aysim Yilmaz; GrΓ©gory Bieler; Olivier Spertini; Ferdy J. Lejeune; Curzio RΓΌegg πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 304 KB πŸ‘ 2 views

Regional administration of high doses of tumor necrosis factor (TNF), interferon gamma (IFNgamma) and melphalan to patients with advanced cancers of the limbs, results in rapid and specific tumor necrosis, while the normal adjacent tissues remain unaffected. The tumor vasculature is selectively dest